Clinical Trials Sponsored by Dacima Software Inc.

Total 154 results

University Health Network, Toronto
Dacima Software Inc.

Withdrawn

Study to Measure and Enhance the Health Related Quality Of Life in Cancer Patients (ME-Q)

Cancer

Canada
Psychology Software Tools, Inc.
National Institute on Aging (NIA)

Completed

CAMCI: Advancing the Use of Computerized Screening in Healthcare

Cognitive Impairment | Cognitive Dysfunction | Cognitive Change | Cognitive Decline

United States
Pacira Pharmaceuticals, Inc

Not yet recruiting

Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity

Spasticity, Cerebral or Spinal Condition
Pacira Pharmaceuticals, Inc

Recruiting

Innovations in Genicular Outcomes Registry (iGOR)

Knee Osteoarthritis

United States
Pacira Pharmaceuticals, Inc

Completed

A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty

Arthritis of the Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Osteoarthritis, Knee

United States, United Kingdom
Pacira Pharmaceuticals, Inc

Completed

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

Knee Osteoarthritis

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

Australia
Pacira Pharmaceuticals, Inc

Terminated

Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee

Post-traumatic Osteoarthritis of the Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States, Canada, Australia
Pacira Pharmaceuticals, Inc

Completed

Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes

Type 2 Diabetes Mellitus | Osteoarthritis of the Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

Postoperative Pain Management

United States
Pacira Pharmaceuticals, Inc

Completed

Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy

Hallux Valgus | Bunionectomy

United States
Pacira Pharmaceuticals, Inc

Completed

Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty

Knee Osteoarthritis | Pain Management

United States
Pacira Pharmaceuticals, Inc

Terminated

Phase 4 Study in Adult Subjects Undergoing Posterior Lumbar Spine Surgeries (FUSION)

Postoperative Pain Management

United States
Pacira Pharmaceuticals, Inc

Completed

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Postoperative Pain | Posterolateral Thoracotomy

Bulgaria, United States, Czechia, Georgia, Poland
Pacira Pharmaceuticals, Inc

Terminated

Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section

Pain

United States
Pacira Pharmaceuticals, Inc

Completed

EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair (702)

Hernia

United States
Pacira Pharmaceuticals, Inc

Completed

EXPAREL Infiltration in Subjects Undergoing Femoral Nerve Block With Bupivacaine HCl for Total Knee Arthroplasty

Pain

United States
Pacira Pharmaceuticals, Inc

Completed

Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy

Postoperative Pain

United States, Georgia
Pacira Pharmaceuticals, Inc

Completed

Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty

Postoperative Pain

United States
Pacira Pharmaceuticals, Inc

Completed

Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair

Postoperative Pain

United States
Pacira Pharmaceuticals, Inc

Completed

Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair

Inguinal Hernia
Pacira Pharmaceuticals, Inc

Completed

Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball

Obesity

United States
Pacira Pharmaceuticals, Inc

Terminated

Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation

Pain

United States
Talima Therapeutics, Inc.

Terminated

A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

Distal Subungual Onychomycosis

United States
Pacira Pharmaceuticals, Inc

Not yet recruiting

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Postoperative Pain
Pacira Pharmaceuticals, Inc

Recruiting

Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers

Healthy

United States
Pacira Pharmaceuticals, Inc
Pacira Pharmaceuticals, Inc

Active, not recruiting

Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

Hong Kong, United States, Denmark, Estonia, Lithuania, Australia, Canada, Romania
Pacira Pharmaceuticals, Inc

Completed

Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects

Histological Response of Tissue to Cold

United States
Pacira Pharmaceuticals, Inc

Completed

Study Evaluating the Treatment of Occipital Neuralgia

Occipital Neuralgia

United States
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States, Canada
Pacira Pharmaceuticals, Inc

Completed

Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device

Upper Limb Spasticity

United States
Pacira Pharmaceuticals, Inc

Completed

Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries (STRIDE)

Bunion | Midfoot Fusion | Total Ankle Arthroplasty | Lower Extremity Surgery | Metatarsophalangeal Fushion | Hindfoot Fushion

United States
Pacira Pharmaceuticals, Inc

Completed

Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section (CHOICE)

Pain Management | Elective Cesarean Section

United States
Pacira Pharmaceuticals, Inc

Completed

Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

Healthy Volunteers

United States
Pacira Pharmaceuticals, Inc

Terminated

EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries (TRANSCEND)

Pain

United States
Pacira Pharmaceuticals, Inc

Terminated

Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy Volunteers

Healthy

United States
Pacira Pharmaceuticals, Inc

Terminated

EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy

Postoperative Pain
Pacira Pharmaceuticals, Inc

Completed

Safety, Efficacy, and Pharmacokinetics of SKY0402 Administered as a Nerve Block in Subjects Undergoing Bunionectomy

Postoperative Pain
Pacira Pharmaceuticals, Inc

Completed

Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections (C-Section)

Pain Management | C-Section

United States
Pacira Pharmaceuticals, Inc

Completed

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL (PLAY)

Postoperative Pain Management

United States
Pacira Pharmaceuticals, Inc

Completed

Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

Pain

United States, Belgium, Denmark
Pacira Pharmaceuticals, Inc

Withdrawn

Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries (STRIDE)

Bunion | Metatarsophalangeal Fusion | Midfoot Fusion | Hindfoot Fusion | Total Ankle Arthroplasty | Forefoot Surgery
Pacira Pharmaceuticals, Inc

Completed

PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery

Pain Management | Spinal Fusion

United States
Pacira Pharmaceuticals, Inc

Completed

Study of Postoperative Analgesia in Bunionectomy

Bunion | Hallux Valgus

United States
Pacira Pharmaceuticals, Inc

Terminated

Dose Finding Posterolateral Thoracotomy Study

Postoperative Pain

United States
Pacira Pharmaceuticals, Inc

Completed

Hepatic Impairment Study: Pharmacokinetics in Healthy and Hepatically Impaired Subjects

Pain | Hepatic Impairment

Poland

3

Subscribe